Melian Agustin

CIK 00018180642 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001818064

Recent Transactions

18 trades

Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−118,000→ 0 total
Disposition from Tender
Forma Therapeutics Holdings, Inc.
Common Stock
2022-10-14−79,000→ 0 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-07-11+118,000→ 118,000 total
Award
Forma Therapeutics Holdings, Inc.
Common Stock
2022-07-11+79,000→ 79,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-04$26.02/sh−333→ 453,529 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-04$24.23/sh−4,711→ 456,829 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-04$23.29/sh−10,678→ 461,540 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-04$25.41/sh−2,967→ 453,862 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-28$24.12/sh−3,750→ 472,218 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-17$24.01/sh−2,950→ 475,968 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-15$24.03/sh−800→ 478,918 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-07-02$19.99/sh−18,586→ 479,718 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-04-05$23.89/sh−18,212→ 498,304 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-22$25.97/sh−3,750→ 516,516 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-02$41.19/sh−54,849→ 520,266 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-01-19+43,750→ 575,115 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-01-19+81,250→ 81,250 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+220,700→ 220,700 total

Companies

Recent Filings

Address

C/O ALLOVIR, INC. 139 MAIN STREET, SUITE 500

CAMBRIDGE, MA, 02142

View on SEC.gov